Waller's first response echoes his June speech: criticizes forward guidance and omits mention of economic outlook
According to Golden Ten Data on July 1, in the first response during the panel discussion, Walsh's remarks were very similar to what we saw at the June interest rate decision: he maintained his criticism of forward guidance (which is part of his push for "institutional reform"), but refrained from providing any details on his current view of the economic outlook. We will have to wait and see if he will share more insights on the economy later.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bayan Resources and its subsidiaries declare force majeure on coal supply agreements
MoffettNathanson raises SpaceX target price to $142
Survival Nearly Doubles! BioNTech (BNTX.US) Lung Cancer Candidate Drug PRESERVE-003 Achieves Success in Late-Stage Trial, Providing Critical Support for Oncology Transformation
BioNTech (BNTX.US) announced on Monday that a late-stage clinical trial demonstrated its candidate drug gotistobart provided a clinically meaningful overall survival benefit compared to standard therapy in a specific type of lung cancer.

